Evommune, Inc. Common Stock (EVMN)
SG&A Expense Growth
74.44%
Fiscal year · Period ending:
EVMN SG&A Expense Growth
Latest reported74.44%period ending
Latest reported74.44%period ending
EVMN FY SG&A Growth (YoY) (0.00% → 74.44%)
Latest values, visible window
High-resolution chart · PNG
EVMN sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 74.4383% | |
| 16.533% | |
| 0% |